Kelajakdagi narxning foydaga nisbati: Relmada Corp (RLMD)
Relmada Therapeutics (RLMD) resmelmetan moddasining tasdiqlanishiga va sanoat gigantlari bilan potentsial alyansga tayanadi. Savdoning yo'qligi sinov xarajatlarining o'sishini chiziqli qiladi. Kompaniyaning forward P/E koeffitsiyenti ushbu jarayonlarni vizuallashtiradi, bunda 0.00 qiymati daromad baholashning ushbu darajasini xarakterlaydi. Shu bilan birga, biznes laboratoriyalarning ekologik izini minimallashtirish uchun energiyatejam texnologiyalarni joriy qilmoqda.
Relmada Corp (RLMD) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- kotirovkalar va tahlilchilar prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- balans bo'yicha xususiy kapital ma'lumotlari:
- qarz majburiyatlari va likvidlik statistikasi:
Umumiy qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati Relmada Therapeutics Inc|RLMD - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Relmada Therapeutics|Tezkor likvidlik koeffitsiyenti relmada.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
RLMD - Yakuniy foyda|Prognoz qilingan kelajakdagi foyda Relmada Therapeutics|RLMD - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Relmada|RLMD - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori Relmada Therapeutics Inc|RLMD - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Relmada Therapeutics|RLMD - So'nggi 12 oy davomida bitta aksiya uchun foyda|Choraklik EPS foyda o'sishi relmada.com|RLMD - Joriy yilda bir aksiya uchun foydaning o'sish sur'ati|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Relmada Therapeutics
Kompaniyaning har tomonlama tahlili:Relmada Therapeutics, Inc. RLMD
Relmada Therapeutics (RLMD) yagona antidepressantning muvaffaqiyatiga kritik darajada bog'liq bo'lib, bu uning bozor kapitalizatsiyasini klinik sinovlar natijalariga nisbatan o'ta sezgir qiladi. Kompaniyaning forward P/E grafigini tahlil qilish orqali investor joriy aksiya narxining prognoz qilingan foydaga nisbatini baholaydi, bozor kutuvlari yagona mahsulotli modelning xatarlarini oqlash-oklamasligini aniqlaydi hamda aktivning haddan tashqari qimmat baholanishi va past baholanishi o'rtasidagi chegarani belgilaydi.
Toʻgʻridan-toʻgʻri raqobatchilar
Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Regencell RGC|Axsome Corp - Kelajakdagi narxning foydaga nisbati|ACAD - Kelajakdagi narxning foydaga nisbati|xenon-pharma.com (XENE) - Prognoz qilingan narxning foydaga nisbati|VKTX: Forvard P/E multiplikatori|Supernus Pharmaceuticals, Inc. (SUPN) - Forvard P/E multiplikatori|CPRX (Catalyst Pharmaceuticals Inc) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati DNLI (Denali Corp)|Forvard P/E multiplikatori HRMY|Forvard P/E multiplikatori biohavenpharma.com (BHVN)|Amylyx Pharmaceuticals, Inc. - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX: Prognoz qilingan narxning foydaga nisbati|Anavex Life Sciences Corp - Kapitalizatsiyaning kelajakdagi foydaga nisbati|CBLL: Forvard P/E multiplikatori|Prothena - Kelajakdagi narx-foyda multiplikatori|ALEC (Alector Inc.) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Annexon Biosciences ANNX|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|NGNE (Neurogene Therapeutics) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ACIU (AC Immune)|Forvard P/E multiplikatori voyagertherapeutics.com VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati SCLX|TVGN: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Alpha Cognition Inc. (ACOG)|Prognoz qilingan narxning foydaga nisbati CGTX|Forvard P/E multiplikatori inhibikase.com|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava Sciences)|Kapitalizatsiyaning kelajakdagi foydaga nisbati ASRT|Forvard P/E multiplikatori COYA (Coya Therapeutics)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati VistaGen Therapeutics, Inc. (VTGN)|Ovid Rx - Forvard P/E multiplikatori|acumenpharm.com (ABOS) - Prognoz qilingan narxning foydaga nisbati|CervoMed (CRVO) - Kelajakdagi narxning foydaga nisbati|ATHE - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati Clene Inc|PEPG: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Jupiter Neurosciences Inc (JUNS)|Kelajakdagi narxning foydaga nisbati ANVS (annovisbio.com)|Kelajakdagi narxning foydaga nisbati Grace Therapeutics GRCE|AIFF - Prognoz qilingan narxning foydaga nisbati|ANEW Medical, Inc. - Forvard P/E multiplikatori|NRSN (NeuroSense Therapeutics) - Narxning kelajakdagi foydaga nisbati|Reviva Pharmaceuticals (RVPH) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati MTVA|NRXS (NeurAxis) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Helius Medical Technologies Inc. HSDT|Prognoz qilingan narxning foydaga nisbati PASG (Passage Bio, Inc.)|Forvard P/E multiplikatori bionomics.com.au (NEUP)|Kelajakdagi narxning foydaga nisbati Minerva Neurosciences NERV|Kelajakdagi narx-foyda multiplikatori ATHA|ADXN - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati Alzamend Neuro, Inc.|cyclerion.com (CYCN) - Kelajakdagi narxning foydaga nisbati|Protagenic Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|KTTA (Pasithea Therapeutics Corp) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Cortigent Medical CRGT|Kelajakdagi narxning foydaga nisbati Avenue Therapeutics, Inc. (ATXI)|Kelajakdagi narxning foydaga nisbati BCLI (Brainstorm Cell Therapeutics Inc.)|Kelajakdagi narxning foydaga nisbati Cara Therapeutics, Inc CARA|CHRO - Prognoz qilingan narxning foydaga nisbati|Eliem - Forvard P/E multiplikatori|ITCI - Forvard P/E multiplikatori|LBPH: Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati MRNS|NKGN (NKGen) - Forvard P/E multiplikatori|Forvard P/E multiplikatori NeuroBo Pharma|Prognoz qilingan narxning foydaga nisbati SAGE (Sage Therapeutics, Inc.)|SNPX (synaptogen.com) - Kelajakdagi narx-foyda multiplikatori|Trevena - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VIGL (Vigil Neuroscience Inc.)|Anew Medical - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Corp)
